Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

NCT02814409 is registered in ClinicalTrials.gov with NHS Greater Glasgow and Clyde as lead sponsor.

NCT NCT02814409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02814409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)
Lead sponsor
NHS Greater Glasgow and Clyde
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2016
Completion date
January 10, 2024
Enrollment
1,858 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke